← Leaderboards
Milton None Wyman
Therapeutic Vision, Inc.
$2,542,342
Attributed
$2,542,342
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $911.1K · FY2007–16$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$2,542,342 · 2
By mechanism
R44$2,434,542 · 1
R43$107,800 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Prevent”
- Lawrence Corey · Fred Hutchinson Cancer Center$609,181,782
- Jeffrey P Krischer · University Of South Florida$605,511,231
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$530,065,238
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$499,311,118
- David Heimbrook · Leidos Biomedical Research, Inc.$496,394,926
Research focus
PreventCompanionsDiabetic CataractPharmaceutical PreparationsVisionBlindnessDiabetes MellitusDiabeticLinkMarketingPreventionClinical TrialsAnimalsInhibitor/AntagonistCanis FamiliarisAldehyde ReductaseCataractCataract ExtractionBaseLensBilateralFeesClinical ResearchFunding
Grant awards (6)
Treatment of Canine Diabetic Cataracts$186,734
R44 · FY2016 · EY · contact PI
Treatment of Canine Diabetic Cataracts$498,270
R44 · FY2015 · EY · contact PI
Treatment of Canine Diabetic Cataracts$223,906
R44 · FY2012 · EY · contact PI
Treatment of Canine Diabetic Cataracts$911,085
R44 · FY2011 · EY · contact PI
Treatment of Canine Diabetic Cataracts$614,547
R44 · FY2010 · EY · contact PI
Treatment for Canine Diabetic Cataracts$107,800
R43 · FY2007 · EY · contact PI